Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Bodick Neil
Relationship:   Chief Scientific Officer
City:   Burlington
State:   MA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   100,153    

Indirect Shares

  389,683      
Direct Value   $913,395    

Indirect Value

  $3,553,909      
Total Shares   489,836      
Total Value   $4,467,304      


Flexion Therapeutics Inc
 $913,395 Flexion Therapeutics Inc
 $913,395
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -48.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Flexion Therapeutics Inc FLXN Chief Scientific Officer 2020-01-03 100,153 2020-01-03 389,683    Premium*  
* Premium Members only  

Records found :    40         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
FLXN Flexion Therapeutics Inc Chief Medical OfficerOfficer   •       –      –    2014-02-11 3 IO $0.00 $0 D/D 0 86,937 -
FLXN Flexion Therapeutics Inc Chief Medical OfficerOfficer   •       –      –    2014-02-11 3 IO $0.00 $0 I/I 0 31,980 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2014-02-18 4 A $0.00 $0 I/I 356,703 388,683 0 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2017-10-06 4 OE $0.00 $0 D/D 4,566 64,503 0 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2018-02-01 4 A $0.00 $0 D/D 10,000 74,605 0 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2018-10-08 4 OE $0.00 $0 D/D 4,566 66,873 0 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 36,000 100,782 0 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2019-10-06 4 OE $0.00 $0 D/D 4,568 105,350 0 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2020-01-03 4 S $0.00 $0 D/D (3,851) 100,153 0 %
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2018-05-11 4 OE $0.16 $6,130 D/D 37,702 112,307 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2017-02-24 4/A OE $2.52 $10,081 D/D 4,000 64,937 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2017-03-17 4/A OE $2.52 $12,602 D/D 5,000 64,937 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2017-04-17 4/A OE $2.52 $12,602 D/D 5,000 64,937 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2017-05-15 4/A OE $2.52 $17,214 D/D 6,830 66,767 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2016-05-16 4 B $9.10 $11,525 D/D 1,250 72,187 2.74 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2016-05-17 4 B $9.60 $7,680 D/D 800 72,987 2.74 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2016-05-19 4 B $10.00 $8,500 D/D 850 75,937 2.74 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2016-05-18 4 B $10.20 $21,420 D/D 2,100 75,087 2.74 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2019-01-03 4 AS $12.36 $9,221 D/D (746) 64,782 0 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2019-10-07 4 D $13.98 $18,817 D/D (1,346) 104,004 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2017-01-20 4 AS $18.35 $91,747 D/D (5,000) 60,937 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2016-12-21 4 AS $18.46 $184,628 D/D (10,000) 65,937 0 -
FLXN Flexion Therapeutics Inc Chief Scientific Officer   •       –      –    2018-10-08 4 D $18.60 $25,017 D/D (1,345) 65,528 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2017-05-15 4/A AS $18.81 $129,448 D/D (6,830) 59,937 0 -
FLXN Flexion Therapeutics Inc Chief Medical Officer   •       –      –    2017-05-15 4 AS $18.81 $129,448 D/D (6,830) 39,107 0 -

  40  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed